Gerty Schreibelt

7.2k total citations
77 papers, 5.3k citations indexed

About

Gerty Schreibelt is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Gerty Schreibelt has authored 77 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Immunology, 36 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Gerty Schreibelt's work include Immunotherapy and Immune Responses (56 papers), Cancer Immunotherapy and Biomarkers (25 papers) and T-cell and B-cell Immunology (23 papers). Gerty Schreibelt is often cited by papers focused on Immunotherapy and Immune Responses (56 papers), Cancer Immunotherapy and Biomarkers (25 papers) and T-cell and B-cell Immunology (23 papers). Gerty Schreibelt collaborates with scholars based in Netherlands, United States and Germany. Gerty Schreibelt's co-authors include I. Jolanda M. de Vries, Carl G. Figdor, Helga E. de Vries, Jack van Horssen, Kalijn F. Bol, Gosse J. Adema, Jurjen Tel, Cornelis J.A. Punt, Winald R. Gerritsen and Erik H.J.G. Aarntzen and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Gerty Schreibelt

76 papers receiving 5.2k citations

Peers

Countries citing papers authored by Gerty Schreibelt

Since Specialization

Citations

This map shows the geographic impact of Gerty Schreibelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerty Schreibelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerty Schreibelt more than expected).

Fields of papers citing papers by Gerty Schreibelt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerty Schreibelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerty Schreibelt. The network helps show where Gerty Schreibelt may publish in the future.

Co-authorship network of co-authors of Gerty Schreibelt

This figure shows the co-authorship network connecting the top 25 collaborators of Gerty Schreibelt. A scholar is included among the top collaborators of Gerty Schreibelt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerty Schreibelt. Gerty Schreibelt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with constitutional mismatch repair deficiency 2025 ·Nature Communications ·(unknown), (unknown), (unknown), Mark A.J. Gorris, Gerty Schreibelt, Sjors Middelkamp, Arjen R. Mensenkamp, Reno S. Bladergroen, Kiek Verrijp, Nicoline Hoogerbrugge, Pieter Wesseling, Rachel S. van der Post, Jan Loeffen, Corrie Gidding, (unknown), I. Jolanda M. de Vries, Ruben van Boxtel, Richarda M. de Voer, Marjolijn C.J. Jongmans, Roland P. Kuiper	2
2	Design of TOLERANT: phase I/II safety assessment of intranodal administration of HSP70/mB29a self-peptide antigen-loaded autologous tolerogenic dendritic cells in patients with rheumatoid arthritis 2024 ·BMJ Open ·(unknown), Gerty Schreibelt, (unknown), Paco M J Welsing, (unknown), (unknown), (unknown), Tjitske Duiveman‐de Boer, Willem van Eden, (unknown), I. Jolanda M. de Vries, Femke Broere, Jacob M. van Laar	4
3	Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome 2021 ·Cancers ·(unknown), Mark A.J. Gorris, (unknown), Marjolijn C.J. Jongmans, (unknown), Roland P. Kuiper, Richarda M. de Voer, Nicoline Hoogerbrugge, Gerty Schreibelt, I. Jolanda M. de Vries	5
4	Immunological responses to adjuvant vaccination with combined CD1c ⁺ myeloid and plasmacytoid dendritic cells in stage III melanoma patients 2021 ·OncoImmunology ·Martine Bloemendal, Kalijn F. Bol, (unknown), Mark A.J. Gorris, Johannes H.W. de Wilt, Sandra Croockewit, Michelle M. van Rossum, Anna L. de Goede, Katja Petry, Rutger H.T. Koornstra, Carl G. Figdor, Winald R. Gerritsen, Gerty Schreibelt, I. Jolanda M. de Vries	22
5	Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy 2018 ·Clinical & Translational Oncology ·Martine Bloemendal, (unknown), (unknown), Winald R. Gerritsen, Carl G. Figdor, Han J. Bonenkamp, Harm Westdorp, (unknown), Rutger H.T. Koornstra, Eddy Adang, Gerty Schreibelt, Petronella B. Ottevanger, I. Jolanda M. de Vries, Kalijn F. Bol	6
6	Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome 2017 ·Cancer Letters ·Harm Westdorp, Sigrid Kolders, Nicoline Hoogerbrugge, I. Jolanda M. de Vries, Marjolijn C.J. Jongmans, Gerty Schreibelt	43
7	Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines 2016 ·Cancer Research ·Ghaith Bakdash, Sonja I. Buschow, Mark A.J. Gorris, Altuna Halilović, Stanleyson V. Hato, Annette E. Sköld, Gerty Schreibelt, Simone P. Sittig, Ruurd Torensma, Tjitske Duiveman‐de Boer, Christoph Schröder, Evelien Smits, Carl G. Figdor, I. Jolanda M. de Vries	90
8	Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function 2016 ·Cell Reports ·(unknown), Till S. M. Mathan, Thien‐Phong Vu Manh, Shivakumar Keerthikumar, Gerty Schreibelt, Jurjen Tel, Tjitske Duiveman‐de Boer, Annette E. Sköld, Annemiek B. van Spriel, I. Jolanda M. de Vries, Martijn A. Huynen, Hans J. C. T. Wessels, Jolein Gloerich, Marc Dalod, Edwin Lasonder, Carl G. Figdor, Sonja I. Buschow	55
9	Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy 2014 ·Expert Review of Clinical Immunology ·Ghaith Bakdash, (unknown), Gerty Schreibelt, Jurjen Tel	22
10	Early predictive value of multifunctional skin-infiltrating lymphocytes in anticancer immunotherapy 2014 ·OncoImmunology ·Florian Wimmers, Erik H.J.G. Aarntzen, Gerty Schreibelt, Joannes F.M. Jacobs, Cornelis J.A. Punt, Carl G. Figdor, I. Jolanda M. de Vries	3
11	Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients 2013 ·Cancer Research ·Jurjen Tel, Erik H.J.G. Aarntzen, Tetsuro Baba, Gerty Schreibelt, Barbara M. Schulte, Daniel Benítez‐Ribas, Otto C. Boerman, Sandra Croockewit, Wim J.G. Oyen, Michelle van Rossum, Gregor Winkels, Pierre G. Coulie, Cornelis J.A. Punt, Carl G. Figdor, I. Jolanda M. de Vries	289
12	Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells 2013 ·Clinical Cancer Research ·Erik H.J.G. Aarntzen, Mangala Srinivas, F. Bonetto, Luis J. Cruz, Pauline Verdijk, Gerty Schreibelt, (unknown), W. Joost Lesterhuis, (unknown), (unknown), Gosse J. Adema, Arend Heerschap, Carl G. Figdor, Wim J.G. Oyen, I. Jolanda M. de Vries	49
13	Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell–Based Vaccination 2012 ·Cancer Research ·Erik H.J.G. Aarntzen, I. Jolanda M. de Vries, W. Joost Lesterhuis, Danita H. Schuurhuis, Joannes F.M. Jacobs, Kalijn F. Bol, Gerty Schreibelt, Roel Mus, Johannes H.W. de Wilt, John B.A.G. Haanen, Dirk Schadendorf, Alexandra Croockewit, Willeke A.M. Blokx, Michelle M. van Rossum, William W. Kwok, Gosse J. Adema, Cornelis J.A. Punt, Carl G. Figdor	131
14	Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell–Based Vaccination in Metastatic Melanoma 2012 ·Cancer Research ·Erik H.J.G. Aarntzen, Kalijn F. Bol, Gerty Schreibelt, Joannes F.M. Jacobs, W. Joost Lesterhuis, Michelle M. van Rossum, Gosse J. Adema, Carl G. Figdor, Cornelis J.A. Punt, I. Jolanda M. de Vries	42
15	Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients 2012 ·Clinical Cancer Research ·Erik H.J.G. Aarntzen, Gerty Schreibelt, Kalijn F. Bol, W. Joost Lesterhuis, Alexandra Croockewit, Johannes H.W. de Wilt, Michelle M. van Rossum, Willeke A.M. Blokx, Joannes F.M. Jacobs, Tjitske Duiveman‐de Boer, Danita H. Schuurhuis, Roel Mus, Kris Thielemans, I. Jolanda M. de Vries, Carl G. Figdor, Cornelis J.A. Punt, Gosse J. Adema	80
16	Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients 2011 ·Clinical Cancer Research ·W. Joost Lesterhuis, I. Jolanda M. de Vries, Gerty Schreibelt, Annechien J.A. Lambeck, Erik H.J.G. Aarntzen, Joannes F.M. Jacobs, Nicole M. Scharenborg, Mandy W.M.M. van de Rakt, Annemiek J. de Boer, Sandra Croockewit, Michelle M. van Rossum, Roel Mus, Wim J.G. Oyen, Otto C. Boerman, Sophie Lucas, Gosse J. Adema, Cornelis J.A. Punt, Carl G. Figdor	138
17	Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice 2011 ·Journal of Clinical Investigation ·W. Joost Lesterhuis, Cornelis J.A. Punt, Stanleyson V. Hato, Dagmar Eleveld-Trancikova, Bas Jansen, Stefan Nierkens, Gerty Schreibelt, Annemiek de Boer, Carla M.L. van Herpen, Johannes H.A.M. Kaanders, J. Han van Krieken, Gosse J. Adema, Carl G. Figdor, I. Jolanda M. de Vries	275
18	Radical changes in multiple sclerosis pathogenesis 2010 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Jack van Horssen, Maarten E. Witte, Gerty Schreibelt, Helga E. de Vries	268
19	Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration 2008 ·Cancer Immunology Immunotherapy ·(unknown), Erik H.J.G. Aarntzen, Pauline Verdijk, Joannes F.M. Jacobs, Danita H. Schuurhuis, Daniel Benítez‐Ribas, Gerty Schreibelt, Mandy W.M.M. van de Rakt, Nicole M. Scharenborg, Annemiek de Boer, Matthijs Kramer, Carl G. Figdor, Cornelis J.A. Punt, Gosse J. Adema, I. Jolanda M. de Vries	122
20	NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions 2006 ·Free Radical Biology and Medicine ·Jack van Horssen, Gerty Schreibelt, Lars Bø, Lisette Montagne, Benjamin Drukarch, F. L. Van Muiswinkel, Helga E. de Vries	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact